These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 32848232)

  • 1. Author Correction: SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.
    Wrobel AG; Benton DJ; Xu P; Roustan C; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
    Nat Struct Mol Biol; 2020 Oct; 27(10):1001. PubMed ID: 32848232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.
    Cheng YW; Chao TL; Li CL; Chiu MF; Kao HC; Wang SH; Pang YH; Lin CH; Tsai YM; Lee WH; Tao MH; Ho TC; Wu PY; Jang LT; Chen PJ; Chang SY; Yeh SH
    Cell Rep; 2020 Oct; 33(2):108254. PubMed ID: 33007239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Therapeutic Targeting of Coronavirus Spike Glycoprotein Priming.
    Barile E; Baggio C; Gambini L; Shiryaev SA; Strongin AY; Pellecchia M
    Molecules; 2020 May; 25(10):. PubMed ID: 32455942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade.
    Coutard B; Valle C; de Lamballerie X; Canard B; Seidah NG; Decroly E
    Antiviral Res; 2020 Apr; 176():104742. PubMed ID: 32057769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.
    Vuong W; Khan MB; Fischer C; Arutyunova E; Lamer T; Shields J; Saffran HA; McKay RT; van Belkum MJ; Joyce MA; Young HS; Tyrrell DL; Vederas JC; Lemieux MJ
    Nat Commun; 2020 Oct; 11(1):5409. PubMed ID: 33082353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Author Correction: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.
    Menachery VD; Yount BL; Debbink K; Agnihothram S; Gralinski LE; Plante JA; Graham RL; Scobey T; Ge XY; Donaldson EF; Randell SH; Lanzavecchia A; Marasco WA; Shi ZL; Baric RS
    Nat Med; 2020 Jul; 26(7):1146. PubMed ID: 32661400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.
    Huo J; Le Bas A; Ruza RR; Duyvesteyn HME; Mikolajek H; Malinauskas T; Tan TK; Rijal P; Dumoux M; Ward PN; Ren J; Zhou D; Harrison PJ; Weckener M; Clare DK; Vogirala VK; Radecke J; Moynié L; Zhao Y; Gilbert-Jaramillo J; Knight ML; Tree JA; Buttigieg KR; Coombes N; Elmore MJ; Carroll MW; Carrique L; Shah PNM; James W; Townsend AR; Stuart DI; Owens RJ; Naismith JH
    Nat Struct Mol Biol; 2020 Nov; 27(11):1094. PubMed ID: 33060850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.
    Laporte M; Raeymaekers V; Van Berwaer R; Vandeput J; Marchand-Casas I; Thibaut HJ; Van Looveren D; Martens K; Hoffmann M; Maes P; Pöhlmann S; Naesens L; Stevaert A
    PLoS Pathog; 2021 Apr; 17(4):e1009500. PubMed ID: 33886690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Author Correction: COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms.
    Ostaszewski M; Mazein A; Gillespie ME; Kuperstein I; Niarakis A; Hermjakob H; Pico AR; Willighagen EL; Evelo CT; Hasenauer J; Schreiber F; Dräger A; Demir E; Wolkenhauer O; Furlong LI; Barillot E; Dopazo J; Orta-Resendiz A; Messina F; Valencia A; Funahashi A; Kitano H; Auffray C; Balling R; Schneider R
    Sci Data; 2020 Jul; 7(1):247. PubMed ID: 32678106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2.
    Mou H; Quinlan BD; Peng H; Liu G; Guo Y; Peng S; Zhang L; Davis-Gardner ME; Gardner MR; Crynen G; DeVaux LB; Voo ZX; Bailey CC; Alpert MD; Rader C; Gack MU; Choe H; Farzan M
    PLoS Pathog; 2021 Apr; 17(4):e1009501. PubMed ID: 33836016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher binding affinity of furin for SARS-CoV-2 spike (S) protein D614G mutant could be associated with higher SARS-CoV-2 infectivity.
    Mohammad A; Alshawaf E; Marafie SK; Abu-Farha M; Abubaker J; Al-Mulla F
    Int J Infect Dis; 2021 Feb; 103():611-616. PubMed ID: 33075532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures and dynamics of the novel S1/S2 protease cleavage site loop of the SARS-CoV-2 spike glycoprotein.
    Lemmin T; Kalbermatter D; Harder D; Plattet P; Fotiadis D
    J Struct Biol X; 2020; 4():100038. PubMed ID: 33043289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected, hospitalized COVID-19 patients.
    Klimstra WB; Tilston-Lunel NL; Nambulli S; Boslett J; McMillen CM; Gilliland T; Dunn MD; Sun C; Wheeler SE; Wells A; Hartman AL; McElroy AK; Reed DS; Rennick LJ; Duprex WP
    bioRxiv; 2020 Jun; ():. PubMed ID: 32607507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
    Drak Alsibai K
    Med Hypotheses; 2020 Oct; 143():109893. PubMed ID: 32512290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.
    Li X; Zai J; Zhao Q; Nie Q; Li Y; Foley BT; Chaillon A
    J Med Virol; 2020 Jun; 92(6):602-611. PubMed ID: 32104911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Author Correction: Pre-existing immunity to SARS-CoV-2: the knowns and unknowns.
    Sette A; Crotty S
    Nat Rev Immunol; 2020 Oct; 20(10):644. PubMed ID: 32807863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Author Correction: Detection of SARS-CoV-2 in nasal swabs using MALDI-MS.
    Nachtigall FM; Pereira A; Trofymchuk OS; Santos LS
    Nat Biotechnol; 2020 Oct; 38(10):1211. PubMed ID: 32943775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Author Correction: A stochastic agent-based model of the SARS-CoV-2 epidemic in France.
    Hoertel N; Blachier M; Blanco C; Olfson M; Massetti M; Rico MS; Limosin F; Leleu H
    Nat Med; 2020 Nov; 26(11):1801. PubMed ID: 33067584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delving deep into the structural aspects of a furin cleavage site inserted into the spike protein of SARS-CoV-2: A structural biophysical perspective.
    Li W
    Biophys Chem; 2020 Sep; 264():106420. PubMed ID: 32622243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China.
    Xu X; Sun J; Nie S; Li H; Kong Y; Liang M; Hou J; Huang X; Li D; Ma T; Peng J; Gao S; Shao Y; Zhu H; Lau JY; Wang G; Xie C; Jiang L; Huang A; Yang Z; Zhang K; Hou FF
    Nat Med; 2020 Sep; 26(9):1494. PubMed ID: 32812013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.